Researchers apply GLP-3R to investigate its simultaneous engagement of GLP-1, GIP, and glucagon receptors, observing complementary effects on insulin secretion, glucagon modulation, and thermogenic energy expenditure. Pre-clinical findings in diet-induced obese rodent models indicate dose-dependent reductions in food intake, substantial body weight loss, and preferential visceral adipose tissue reduction through integrated central and peripheral pathways.
This long-acting triple agonist facilitates examination of synergistic receptor crosstalk, metabolic flexibility, and glucose regulation in models of obesity, type 2 diabetes, and metabolic dysfunction-associated steatohepatitis.
Scientific Overview of GLP-3R Applications
Pre-clinical models demonstrate GLP-3R’s engagement with triple-receptor mechanisms:
- Activation of GLP-1 receptors to stimulate glucose-dependent insulin secretion and suppress glucagon release in pancreatic islet models.
- Engagement of GIP receptors to enhance insulinotropic effects and improve metabolic sensitivity in adipose and hepatic systems.
- Stimulation of glucagon receptors to increase energy expenditure and promote fat oxidation in adipose and liver tissue.
- Synergistic reduction in body weight and visceral adipose tissue through coordinated appetite suppression and thermogenic activity in obesity models.
- Modulation of postprandial glucose excursions, insulin sensitivity, and liver fat content in metabolic challenge paradigms.
- Support for investigations into cardiometabolic parameter improvements and hepatic lipid clearance in steatohepatitis-related research.
For further details on triple-agonist signaling, metabolic regulation, and energy balance pathways in pre-clinical research, refer to the Peptide Sciences or About Peptides sections.
Commitment to Research-Grade Quality at National Science Labs
National Science Labs manufactures GLP-3R under strict GMP-compliant protocols to deliver batch-to-batch consistency and reliability for pre-clinical experiments. Each lot undergoes independent third-party analysis, confirming:
- Purity ≥99.9% via HPLC
- Accurate structural identity and lipidation verification
- Comprehensive Certificate of Analysis (CoA) available for download per batch
For Research Use Only. This product is intended solely for in vitro and in vivo pre-clinical research by qualified investigators. Statements concerning this peptide have not been evaluated by the FDA.
Begin Your Triple-Agonist Research
Access current limited batches of high-purity GLP-3R to maintain optimal stability and performance in your metabolic regulation studies.
